Search research articles
Contact Us
Filters
Showing results (521-530 of 543) with videos related to
Page
of 55
Sort By:
Journal of Cellular Biochemistry
|
May 23, 2014
Osteoblasts protect AML cells from SDF-1-induced apoptosis
Kimberly N Kremer, Amel Dudakovic, Meghan E McGee-Lawrence, et al.
Iscience
|
December 17, 2024
Identification and development of TRPM4 antagonists to counteract neuronal excitotoxicity
Lars Binkle-Ladisch, Andy Pironet, Andrea Zaliani, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 4, 2002
Phase I and pharmacokinetic studies of PNU-159548, a novel alkycycline, administered intravenously to patients with advanced solid tumours
M J A de Jonge, J Verweij, A van der Gaast, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 8, 2006
Concerted escalation of dose and dosing duration in a phase I study of the oral camptothecin gimatecan (ST1481) in patients with advanced solid tumors
C Sessa, S Cresta, T Cerny, et al.
Vector Borne and Zoonotic Diseases (Larchmont, N.Y.)
|
February 21, 2015
Epizootiology of Tacaribe serocomplex viruses (Arenaviridae) associated with neotomine rodents (Cricetidae, Neotominae) in southern California
Mary Louise Milazzo, Maria N B Cajimat, Matthew R Mauldin, et al.
Journal of Hematotherapy
|
May 23, 1998
CD34 augmentation improves allogeneic T cell-depleted bone marrow engraftment
S J Noga, A Seber, J M Davis, et al.
Scientific Reports
|
October 7, 2021
Eliapixant is a selective P2X3 receptor antagonist for the treatment of disorders associated with hypersensitive nerve fibers
Adam J Davenport, Ioana Neagoe, Nico Bräuer, et al.
ACS Chemical Biology
|
May 16, 2025
Discovery and Characterization of Small Molecule Inhibitors Targeting Exonuclease 1 for Homologous Recombination-Deficient Cancer Therapy
Yixing Wang, Jessica D Hess, Chen Wang, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
June 25, 1999
SIB-1757 and SIB-1893: selective, noncompetitive antagonists of metabotropic glutamate receptor type 5
M A Varney, N D Cosford, C Jachec, et al.
Bone Marrow Transplantation
|
December 16, 1998
CD34+ stem cell augmentation of elutriated allogeneic bone marrow grafts: results of a phase II clinical trial of engraftment and graft-versus-host disease prophylaxis in high-risk hematologic malignancies
P V O'Donnell, R J Jones, G B Vogelsang, et al.
Page
of 55
Search research articles
Search
Showing results (521-530 of 543) with videos related to
Sort By:
Page
of 55
Journal of Cellular Biochemistry
|
May 23, 2014
Osteoblasts protect AML cells from SDF-1-induced apoptosis
Kimberly N Kremer, Amel Dudakovic, Meghan E McGee-Lawrence, et al.
Iscience
|
December 17, 2024
Identification and development of TRPM4 antagonists to counteract neuronal excitotoxicity
Lars Binkle-Ladisch, Andy Pironet, Andrea Zaliani, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 4, 2002
Phase I and pharmacokinetic studies of PNU-159548, a novel alkycycline, administered intravenously to patients with advanced solid tumours
M J A de Jonge, J Verweij, A van der Gaast, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 8, 2006
Concerted escalation of dose and dosing duration in a phase I study of the oral camptothecin gimatecan (ST1481) in patients with advanced solid tumors
C Sessa, S Cresta, T Cerny, et al.
Vector Borne and Zoonotic Diseases (Larchmont, N.Y.)
|
February 21, 2015
Epizootiology of Tacaribe serocomplex viruses (Arenaviridae) associated with neotomine rodents (Cricetidae, Neotominae) in southern California
Mary Louise Milazzo, Maria N B Cajimat, Matthew R Mauldin, et al.
Journal of Hematotherapy
|
May 23, 1998
CD34 augmentation improves allogeneic T cell-depleted bone marrow engraftment
S J Noga, A Seber, J M Davis, et al.
Scientific Reports
|
October 7, 2021
Eliapixant is a selective P2X3 receptor antagonist for the treatment of disorders associated with hypersensitive nerve fibers
Adam J Davenport, Ioana Neagoe, Nico Bräuer, et al.
ACS Chemical Biology
|
May 16, 2025
Discovery and Characterization of Small Molecule Inhibitors Targeting Exonuclease 1 for Homologous Recombination-Deficient Cancer Therapy
Yixing Wang, Jessica D Hess, Chen Wang, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
June 25, 1999
SIB-1757 and SIB-1893: selective, noncompetitive antagonists of metabotropic glutamate receptor type 5
M A Varney, N D Cosford, C Jachec, et al.
Bone Marrow Transplantation
|
December 16, 1998
CD34+ stem cell augmentation of elutriated allogeneic bone marrow grafts: results of a phase II clinical trial of engraftment and graft-versus-host disease prophylaxis in high-risk hematologic malignancies
P V O'Donnell, R J Jones, G B Vogelsang, et al.
Page
of 55